Authorization Under Uncertainty
Authorization Under Uncertainty is a regulatory decision-making framework that permits the provisional approval of medical products based on preliminary evidence, pending the verification of clinical benefit through post-marketing studies.
10
Publications
281
Citations
58
Authors
42
Institutions
Publications per year
2017–2026
7
10
Caridad Pontes, J.M. Fontanet, Roser Vives et al. · Orphanet Journal of Rare Diseases · 2018 · 67 citations · Full text
Pharmacy, Pharmaceutical Policy, Drug Approval Processes +16
Un. Ece. Secretariat · 2003 · 52 citations
1–5 of 10
58
2
h-index
1
h-index
1
h-index
1 publications · 52 citations
1
h-index
1
h-index
1–5 of 58
42
Utrecht University
Utrecht, The Netherlands
4 h-index
12 publications
314 citations
Medical University of Vienna
Vienna, Austria
2 h-index
2 publications
83 citations
University Medical Center Utrecht
Utrecht, The Netherlands
2 h-index
3 publications
151 citations
Institute for Sustainable Development
Ljubljana, Slovenia
2 h-index
2 publications
40 citations
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Barcelona, Spain
1 h-index
1 publications
67 citations
Zorginstituut Nederland
Diemen, The Netherlands
1 h-index
3 publications
48 citations
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Barcelona, Spain
1 h-index
2 publications
134 citations
Rijksinstituut voor Ziekte- en Invaliditeitsverzekering
Brussels, Belgium
1 h-index
2 publications
32 citations
1–8 of 42
2 publications · 33 citations
2
h-index
1 publications · 23 citations
1
h-index
1 publications · 13 citations
1
h-index
CPT · 1 publications · 17 citations
1
h-index
1 publications · 47 citations
1
h-index
1–5